Andújar-Sánchez, F, Cantó-Santos, J, Fernández-Garibay, X, Valls-Roca, L, Tobías, E, Guitart-Mampel, M, García-García, FJ, Laudo, B, Vilaseca-Capel, A, Padrosa, J, Moreno-Lozano, PJ, Grau-Junyent, JM, Matas, A, Gallardo, E, Fernández-Costa, J, Ramón-Azcón, J, Milisenda, JC, Garrabou, G. Novel patient-derived 2D and 3D muscle models in inclusion body myositis. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).

Villaplana, VDS, Muñoz, N, Puntes, M, Badimón, L, Padró, T. Cardiometabolic sex-specific response to a natural polysaccharide in individuals with obesity. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).

Camacho-Téllez, V, Castro, MN, Wainsztein, AE, Goldberg, X, De Pino, G, Costanzo, EY, Cardoner, N, Menchón, JM, Soriano-Mas, C, Guinjoan, SM, Villarreal, MF. Childhood adversity modulates structural brain changes in borderline personality but not in major depression disorder. PSYCHIATRY RESEARCH-NEUROIMAGING. 2024; 340DOI:10.1016/j.pscychresns.2024.111803. PMID:38460393. IF:2.100(Q1/1D).

De la Peña-Arteaga, V, Chavarría-Elizondo, P, Juaneda-Seguí, A, Martínez-Zalacaín, I, Morgado, P, Menchón, JM, Picó-Pérez, M, Fullana, MA, Soriano-Mas, C. Trait anxiety is associated with attentional brain networks. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2024; 83DOI:10.1016/j.euroneuro.2024.02.013. PMID:38492550. IF:6.700(Q1/1D).

Almodóvar-Payá, C, Guardiola-Ripoll, M, Giralt-López, M, Oscoz-Irurozqui, M, Canales-Rodríguez, EJ, Madre, M, Soler-Vidal, J, Ramiro, N, Callado, LF, Arias, B, Gallego, C, Pomarol-Clotet, E, Fatjó-Vilas, M. NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia. Brain Structure & Function. 2024; 229(5)DOI:10.1007/s00429-024-02793-5. PMID:38720004. IF:2.900(Q1/1D).

Chatterjee, M, Özdemir, S, Fritz, C, Möbius, W, Kleineidam, L, Mandelkow, E, Biernat, J, Dogdu, C, Peters, O, Cosma, NC, Wang, X, Schneider, LS, Priller, J, Spruth, E, Kühn, AA, Krause, P, Klockgether, T, Vogt, IR, Kimmich, O, Spottke, A, Hoffmann, DC, Fliessbach, K, Miklitz, C, McCormick, C, Weydt, P, Falkenburger, B, Brandt, M, Guenther, R, Dinter, E, Wiltfang, J, Hansen, N, Bähr, M, Zerr, I, Flöel, A, Nestor, PJ, Düzel, E, Glanz, W, Incesoy, E, Bürger, K, Janowitz, D, Perneczky, R, Rauchmann, BS, Hopfner, F, Wagemann, O, Levin, J, Teipel, S, Kilimann, I, Goerss, D, Prudlo, J, Gasser, T, Brockmann, K, Mengel, D, Zimmermann, M, Synofzik, M, Wilke, C, Selma-Gonzáalez, J, Turon-Sans, J, Santos-Santos, MA, Alcolea, D, Rubio-Guerra, S, Fortea, J, Carbayo, A, Lleó, A, Rojas-García, R, Illán-Gala, I, Wagner, M, Frommann, I, Roeske, S, Bertram, L, Heneka, MT, Brosseron, F, Ramirez, A, Schmid, M, Beschorner, R, Halle, A, Herms, J, Neumann, M, Barthélemy, NR, Bateman, RJ, Rizzu, P, Heutink, P, Dols-Icardo, O, Höglinger, G, Hermann, A, Schneider, A. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. NATURE MEDICINE. 2024; 30(6)DOI:10.1038/s41591-024-02937-4. PMID:38890531. IF:50.000(Q1/1D).